SCHEMBL2456565

SCHEMBL2456565

O=c1c(Cc2cccc(Cl)c2)c(C2CC2)[nH]c2ncnn12

nearest known ligand 0.50

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 5/20 0.50
CCR5 P51681 2/20 0.46
NR3C1 P04150 9/20 0.42
ENPP1 P22413 1/20 0.42
NR3C2 P08235 2/20 0.42
PGR P06401 1/20 0.42
PLAT P00750 2/20 0.39
PDE1B Q01064 1/20 0.38
ALKBH3 Q96Q83 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2460219 0.96 CCR2 (0.46) CCR2CCR5NR3C1ENPP1NR3C2
SCHEMBL2456663 0.96 CCR2 (0.48) CCR2CCR5NR3C1ENPP1NR3C2
SCHEMBL2457070 0.93 CCR2 (0.44) CCR2CCR5NR3C1ENPP1NR3C2
SCHEMBL2462973 0.87 CCR2 (0.39) CCR2CCR5PLATPDE1B
SCHEMBL2456672 0.86 CCR2 (0.41) CCR2CCR5NR3C1ENPP1NR3C2
SCHEMBL2456675 0.86 CCR2 (0.41) CCR2CCR5NR3C1ENPP1NR3C2
SCHEMBL2459450 0.84 ENPP1 (0.47) CCR2CCR5ENPP1PDE1BALKBH3
SCHEMBL2455160 0.83 CCR2 (0.43) CCR2NR3C1ENPP1PDE1B
SCHEMBL2460011 0.83 CCR2 (0.43) CCR2CCR5NR3C1
SCHEMBL2455177 0.83 NR3C1 (0.46) CCR2CCR5NR3C1ENPP1NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO claimed
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed